Effects Study of Serum Adiponectin Level in Osteoporosis Disease
DOI:
https://doi.org/10.47750/pnr.2022.13.03.084Keywords:
Osteoporosis (OP), Adiponectin, and osteoblast.Abstract
Subject: Osteoporosis (OP) is a skeletal system disorder that suffers from low bone mass, occurs defect of microarchitectural of bone tissue results in bone fracture. OP is common frequent in old age persons. Adiponectin is the peptide hormone produced mainly by adipose tissues, that acts for various functions for example mediator at many metabolic pathways in the human body.
The objective of the Study: Study the role of serum Adiponectin hormone level in Osteoporosis patients.
Materials and Methods: This study was done on 20 patients with OP disease and 20 healthy persons (control), all subjects’ age in this study was more than 50 years of both genders. After obtaining serum, immediately used quantity method (immunoassay) for the measured level of Adiponectin concentration.
Results: This study shows the elevation of serum Adiponectin concentration level in the OP group compared with the healthy control group.
Conclusion: This study confirms that serum Adiponectin concentration level can act as a stimulation factor in OP disease to activate osteoblast and prevent bone fracture.